IL95061A0 - Antagonists of gm-csf derived from the carboxyl terminus - Google Patents
Antagonists of gm-csf derived from the carboxyl terminusInfo
- Publication number
- IL95061A0 IL95061A0 IL95061A IL9506190A IL95061A0 IL 95061 A0 IL95061 A0 IL 95061A0 IL 95061 A IL95061 A IL 95061A IL 9506190 A IL9506190 A IL 9506190A IL 95061 A0 IL95061 A0 IL 95061A0
- Authority
- IL
- Israel
- Prior art keywords
- antagonists
- carboxyl terminus
- csf derived
- csf
- derived
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/243—Colony Stimulating Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37984689A | 1989-08-14 | 1989-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL95061A0 true IL95061A0 (en) | 1991-06-10 |
Family
ID=23498958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL95061A IL95061A0 (en) | 1989-07-14 | 1990-07-12 | Antagonists of gm-csf derived from the carboxyl terminus |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5475087A (de) |
| EP (2) | EP0482086A1 (de) |
| JP (1) | JPH04503815A (de) |
| KR (1) | KR920701246A (de) |
| AU (1) | AU630496B2 (de) |
| CA (1) | CA2062975A1 (de) |
| FI (1) | FI920150A0 (de) |
| HU (1) | HUT63181A (de) |
| IE (1) | IE902562A1 (de) |
| IL (1) | IL95061A0 (de) |
| MY (1) | MY105946A (de) |
| NO (1) | NO920176D0 (de) |
| NZ (1) | NZ234479A (de) |
| PH (1) | PH27534A (de) |
| WO (1) | WO1991001330A1 (de) |
| ZA (1) | ZA905480B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2060741A1 (en) * | 1991-02-11 | 1992-08-12 | Robert S. Greenfield | Gm-csf inhibiting oligopeptides |
| EP0673389A1 (de) * | 1992-11-19 | 1995-09-27 | Dana Farber Cancer Institute | Antikörper gegen den gm-csf rezeptor und dessen verwendung |
| DK96493D0 (da) * | 1993-08-26 | 1993-08-26 | Mouritsen Og Elsner Aps | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
| FR2730154B1 (fr) * | 1995-02-08 | 1997-07-11 | Stephanois Rech | Dispositif de mesure des efforts exerces lors de la marche |
| AUPN378095A0 (en) * | 1995-06-23 | 1995-07-20 | Bresagen Limited | Haemopoietic growth factor antagonists and uses therefor |
| US8062637B2 (en) * | 2000-05-08 | 2011-11-22 | Morphosys Ag | Methods of ameliorating inflammatory disease using an uPA antagonist |
| US7455836B2 (en) * | 2000-05-08 | 2008-11-25 | The University Of Melbourne | Method of treatment and agents useful for same |
| US7247618B2 (en) * | 2001-04-30 | 2007-07-24 | Tripathi Rajavashisth | Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling |
| AR045563A1 (es) | 2003-09-10 | 2005-11-02 | Warner Lambert Co | Anticuerpos dirigidos a m-csf |
| EP1712241A1 (de) | 2005-04-15 | 2006-10-18 | Centre National De La Recherche Scientifique (Cnrs) | Intratumoral applizierbare Zusammensetzung zur Krebsbehandlung |
| AU2005100402B4 (en) * | 2005-05-16 | 2006-01-12 | Novomatic Ag | Method for increased chances at an award on a Gaming Machine |
| CN101501070B (zh) | 2006-02-08 | 2013-12-25 | 诺福泰克公司 | 抗原性gm-csf肽和针对gm-csf的抗体 |
| AU2013201228B2 (en) * | 2006-02-08 | 2016-01-21 | Eisai, Inc. | Antigenic gm-csf peptides and antibodies to gm-csf |
| NZ598345A (en) * | 2006-11-21 | 2013-09-27 | Kalobios Pharmaceuticals Inc | Methods of treating chronic inflammatory diseases using a gm-csf antagonist |
| US8398972B2 (en) | 2006-11-21 | 2013-03-19 | Kalobios Pharmaceuticals, Inc. | Methods of treating dementia using a GM-CSF antagonist |
| TW200918553A (en) * | 2007-09-18 | 2009-05-01 | Amgen Inc | Human GM-CSF antigen binding proteins |
| ES2401536T3 (es) | 2007-11-13 | 2013-04-22 | Evec Inc. | Anticuerpos monoclonales que se unen a HGM-CSF y composiciones medicinales que los comprenden |
| US8475796B2 (en) * | 2008-12-22 | 2013-07-02 | University Of Melbourne | Method of treating pain using an antagonist of GM-CSF |
| CN106397591A (zh) | 2008-12-22 | 2017-02-15 | 墨尔本大学 | 骨关节炎治疗 |
| WO2013026059A1 (en) | 2011-08-18 | 2013-02-21 | New York University | Inhibition of oncogenic kras-induced gm-csf production and function |
| CA2856329A1 (en) * | 2011-11-17 | 2013-05-23 | Nencki Institute Of Experimental Biology | Compositions and methods for treating glioma |
| WO2022171868A1 (en) | 2021-02-15 | 2022-08-18 | Splifar S.A. | Method for applying a seal to a plate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL63224A (en) * | 1980-07-17 | 1985-05-31 | Scripps Clinic Res | Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom |
| WO1986000639A1 (en) * | 1984-07-06 | 1986-01-30 | Sandoz Ag | Lymphokine production and purification |
| AU588819B2 (en) * | 1984-10-29 | 1989-09-28 | Immunex Corporation | Cloning of human granulocyte-macrophage colony stimulating factor gene |
-
1990
- 1990-07-12 EP EP90911581A patent/EP0482086A1/de active Pending
- 1990-07-12 PH PH40830A patent/PH27534A/en unknown
- 1990-07-12 KR KR1019910700279A patent/KR920701246A/ko not_active Application Discontinuation
- 1990-07-12 ZA ZA905480A patent/ZA905480B/xx unknown
- 1990-07-12 NZ NZ234479A patent/NZ234479A/en unknown
- 1990-07-12 JP JP2511280A patent/JPH04503815A/ja active Pending
- 1990-07-12 MY MYPI90001168A patent/MY105946A/en unknown
- 1990-07-12 AU AU61487/90A patent/AU630496B2/en not_active Ceased
- 1990-07-12 EP EP90113375A patent/EP0409091A1/de not_active Withdrawn
- 1990-07-12 WO PCT/US1990/003811 patent/WO1991001330A1/en not_active Application Discontinuation
- 1990-07-12 HU HU9287A patent/HUT63181A/hu unknown
- 1990-07-12 CA CA002062975A patent/CA2062975A1/en not_active Abandoned
- 1990-07-12 IL IL95061A patent/IL95061A0/xx unknown
- 1990-07-13 IE IE256290A patent/IE902562A1/en unknown
-
1992
- 1992-01-14 FI FI920150A patent/FI920150A0/fi not_active Application Discontinuation
- 1992-01-14 NO NO920176A patent/NO920176D0/no unknown
-
1994
- 1994-02-04 US US08/192,310 patent/US5475087A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0482086A1 (de) | 1992-04-29 |
| CA2062975A1 (en) | 1991-01-15 |
| HUT63181A (en) | 1993-07-28 |
| NO920176L (no) | 1992-01-14 |
| EP0409091A1 (de) | 1991-01-23 |
| ZA905480B (en) | 1991-03-27 |
| NZ234479A (en) | 1992-03-26 |
| WO1991001330A1 (en) | 1991-02-07 |
| MY105946A (en) | 1995-02-28 |
| NO920176D0 (no) | 1992-01-14 |
| IE902562A1 (en) | 1991-02-27 |
| JPH04503815A (ja) | 1992-07-09 |
| AU6148790A (en) | 1991-02-22 |
| KR920701246A (ko) | 1992-08-11 |
| FI920150A0 (fi) | 1992-01-14 |
| HU9200087D0 (en) | 1992-04-28 |
| AU630496B2 (en) | 1992-10-29 |
| PH27534A (en) | 1993-08-18 |
| US5475087A (en) | 1995-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL95061A0 (en) | Antagonists of gm-csf derived from the carboxyl terminus | |
| EP0417959A3 (en) | An assembly for locating the position of an object | |
| ZA856449B (en) | Gnrh antagonists vi | |
| IL65211A0 (en) | Polypeptide antagonists arginine vasopressin | |
| GB8914862D0 (en) | Coating compositions | |
| IL96475A0 (en) | Chimeric proteins | |
| AU587922B2 (en) | Leukotriene antagonists | |
| AU2503884A (en) | Gnrh antagonists | |
| GB8925298D0 (en) | Object tracking | |
| AU591459B2 (en) | cDNA probe for the detection of bluetongue virus | |
| JPS6466174A (en) | Leukotriene antagonist | |
| EP0418863A3 (en) | Nmda antagonists | |
| GB8915356D0 (en) | Coating compositions | |
| GB8924829D0 (en) | Object tracking | |
| AU1619288A (en) | Vasopressin antagonists | |
| GB8925211D0 (en) | Improved impedance bond | |
| GB8923750D0 (en) | Sonobuoy location | |
| ZA907896B (en) | Substituted acrylamido-penicillanic esters | |
| ZA905205B (en) | Theunis christiaan verster the location of objects | |
| IE871656L (en) | Leukotriene antagonists | |
| GB8907660D0 (en) | Polypeptide | |
| BG47918A1 (en) | Isolated analogous signal adapter | |
| ZA887993B (en) | The tracking of objects | |
| IE894106L (en) | Expression of the plasmodium circumsporozite protein in¹insects | |
| ZA907310B (en) | Nmda antagonists |